StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3025% above fair value
$1410.99−6.55 (-0.46%)

Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%

Eli Lilly Non-GAAP effective tax rate by Quarter

Non-GAAP effective tax rate (%) (%)

QuarterlyAnnual

Eli Lilly Non-GAAP effective tax rate: 22.2% in Q2 2026, up 5.7 pts from a year earlier.

Latest, Q2 2026
22.2%
Period ended Jun 30, 2026
Change on a year earlier
+5.7 pts
16.5% in Q2 2025
History
18 quarters
Since Q1 2022
Sources
14
Documents cited below

Where the Q2 2026 figure comes from

“|| Effective tax rate - Non-GAAP (3) | 22.2 | % | 16.5 | % | 19.4 | % | 17.8 | %”

Source: Earnings Release (Form 8-K FY2026Q2 EX-99.1) (filed 2026-08-05) ↗

Reported in Form 8-K Non-GAAP Reconciliation Schedules.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNon-GAAP effective tax rate (%) (%)Year on yearSource
Q2 2026Jun 30, 202622.2%+5.7 ptsEarnings Release (Form 8-K FY2026Q2 EX-99.1) (filed 2026-08-05) ↗
Q1 2026Mar 31, 202616.5%-3.7 ptsEarnings Release (Form 8-K FY2026Q1 EX-99.1) (filed 2026-04-30) ↗
Q4 2025Dec 31, 202519.7%+6.5 ptsEarnings Release (Form 8-K FY2025Q4 EX-99.1) (filed 2026-02-04) ↗
Q3 2025Sep 30, 202517.7%-19.9 ptsEarnings Release (Form 8-K FY2025Q3 EX-99.1) (filed 2025-10-30) ↗
Q2 2025Jun 30, 202516.5%0.0 ptsEarnings Release (Form 8-K FY2025Q2 EX-99.1) (filed 2025-08-07) ↗
Q1 2025Mar 31, 202520.2%+8.3 ptsEarnings Release (Form 8-K FY2025Q1 EX-99.1) (filed 2025-05-01) ↗
Q4 2024Dec 31, 202413.2%+0.1 ptsEarnings Release (Form 8-K FY2024Q4 EX-99.1) (filed 2025-02-06) ↗
Q3 2024Sep 30, 202437.6%-47.0 ptsEarnings Release (Form 8-K FY2024Q3 EX-99.1) (filed 2024-10-30) ↗
Q2 2024Jun 30, 202416.5%+0.4 ptsEarnings Release (Form 8-K FY2024Q2 EX-99.1) (filed 2024-08-08) ↗
Q1 2024Mar 31, 202411.9%-0.9 ptsEarnings Release (Form 8-K FY2024Q1 EX-99.1) (filed 2024-04-30) ↗
Q4 2023Dec 31, 202313.1%+5.8 ptsEarnings Release (Form 8-K FY2023Q4 EX-99.1) (filed 2024-02-06) ↗
Q3 2023Sep 30, 202384.6%+73.9 ptsEarnings Release (Form 8-K FY2023Q3 EX-99.1) (filed 2023-11-02) ↗
Q2 2023Jun 30, 202316.1%+1.9 ptsEarnings Release (Form 8-K FY2023Q2 EX-99.1) (filed 2023-08-08) ↗
Q1 2023Mar 31, 202312.8%+2.5 ptsEarnings Release (Form 8-K FY2023Q1 EX-99.1) (filed 2023-04-27) ↗
Q4 2022Dec 31, 20227.3%–Earnings Release (Form 8-K FY2023Q4 EX-99.1) (filed 2024-02-06) ↗
Q3 2022Sep 30, 202210.7%–Earnings Release (Form 8-K FY2023Q3 EX-99.1) (filed 2023-11-02) ↗

Cite this data

StockData. (2026). Eli Lilly Non-GAAP effective tax rate (%), quarterly Q1 2022–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/tax-rate-nongaap

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.